Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.34 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17801557 | 0.83 | TSHR (0.42) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL10818200 | 0.80 | TSHR (0.46) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL1520811 | 0.79 | FAAH (0.40) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL26190499 | 0.79 | SMN1; SMN2 (0.38) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL17801624 | 0.79 | FAAH (0.40) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL23763979 | 0.79 | HTT (0.43) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL1520813 | 0.79 | FAAH (0.40) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL9481967 | 0.77 | FAAH (0.39) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL157278 | 0.75 | SMN1; SMN2 (0.42) | FAAHSMN1; SMN2TSHRMAPTKMT2A | |
| SCHEMBL157277 | 0.75 | SMN1; SMN2 (0.42) | FAAHSMN1; SMN2TSHRMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307738-B1 | ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE | UNIV MICHIGAN REGENTS (US) | 2022-04-20 | — | — | EP | disclosed |
| US-20190241582-A1 | Triazole ACC inhibitors and uses thereof | Nimbus Apollo, Inc. | 2019-08-08 | — | — | US | disclosed |
| WO-2017091617-A1 | TRIAZOLE ACC INHIBITORS AND USES THEREOF | GILEAD APOLLO, LLC (US) | 2017-06-01 | — | — | WO | disclosed |
| US-8714088-B2 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORPORATION (JP) | 2014-05-06 | — | — | US | disclosed |
| US-8151705-B2 | Method of preparing lithographic printing plate | FUJIFILM CORPORATION (JP) | 2012-04-10 | — | — | US | disclosed |
| US-8008379-B2 | Fluorescent polymer fine particle, method for forming thereof, fluorescence detection kit, and method for detecting fluorescence | FUJIFILM CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20100081771-A1 | METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2010-04-01 | — | — | US | disclosed |
| US-20090114108-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2009-05-07 | — | — | US | disclosed |
| US-7507525-B2 | Polymerizable composition and lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2009-03-24 | — | — | US | disclosed |
| US-7279539-B2 | Alkali-soluble polymer and polymerizable composition thereof | FUJIFILM CORPORATION (JP) | 2007-10-09 | — | — | US | disclosed |
| US-20070105990-A1 | Fluorescent polymer fine particle, method for forming thereof, fluorescence detection kit, and method for detecting fluorescence | FUJIFILM CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241582-A1 | Triazole ACC inhibitors and uses thereof | ACACA, ACACB, ACAT1 | RIPK1 2051/4885FAAH 1025/4885SMN1; SMN2 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.